These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration. Russell AS; Kaiser J; Lao VS J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120 [TBL] [Abstract][Full Text] [Related]
4. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody. Meyers-Elliott RH; Chitjian PA Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986 [TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice. Mogensen SC Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467 [TBL] [Abstract][Full Text] [Related]
6. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Sheridan JF; Aurelian L Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056 [TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. Arvin AM; Pollard RB; Rasmussen LE; Merigan TC J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336 [TBL] [Abstract][Full Text] [Related]
8. Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs. Koszinowski U; Bandlow G Clin Exp Immunol; 1975 Apr; 20(1):143-54. PubMed ID: 173485 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity to herpes simplex virus in man. Russell AS J Infect Dis; 1974 Feb; 129(2):142-6. PubMed ID: 4359402 [No Abstract] [Full Text] [Related]
10. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. O'Reilly RJ; Chibbaro A; Anger E; Lopez C J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524 [TBL] [Abstract][Full Text] [Related]
11. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans. Shillitoe EJ; Wilton JM; Lehner T Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372 [TBL] [Abstract][Full Text] [Related]
12. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains. Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852 [TBL] [Abstract][Full Text] [Related]